L&G Global Health & Pharma Index I Acc (FUND:B0CNH38) - Fund price - Overview

Fund Report

Legal & General Global Health & Pharmaceuticals Index Trust I Class Accumulation

Key Stats
Morningstar® CategorySector Equity Healthcare
Manager Name-
Inception Date01/11/2000
NAV 18/01/2019GBX 79.93
Day Change0.67%
12 Month Yield-
ISINGB00B0CNH387
SEDOLB0CNH38
Dividend FrequencyAnnually
Net Assets (mil) 30/04/2018425.80 GBP
Wrapper AvailabilityAll
Our Minimum Initial Investment1.00 Share
Pricing FrequencyDaily
Dealing Cut off Time13:00:00
Regular InvestmentYes
Actual Initial Charge0.00%
Exit Charge-
Custody ChargeYes
Ongoing Cost0.31%
AMC0.31%
Fund Rebate0.00%

Morningstar Rating™

4 Stars

Morningstar Sustainability Rating

Above Average

Above Average


Sustainability Rating as of 30/11/2018

Benchmarks

Fund Benchmark

FTSE Wld Health & Pharmaceutical

Morningstar® Benchmark

MSCI World/Health Care NR USD

Growth Of 10,000 (GBP) 31/12/2018

How has this security performed
201320142015201620172018
Fund32.6226.3212.2612.2910.027.37
Category31.9225.2311.407.359.962.70
Benchmark33.7325.4412.7711.169.438.89
  • Fund: Legal & General Global Health & Pharmaceuticals Index Trust I Class Accumulation
  • Category: Sector Equity Healthcare
  • Benchmark: MSCI World/Health Care NR USD
Trailing Returns % (GBP) 18/01/2019
FundCatBmark
YTD3.184.573.14
3 Years Annualised12.8011.1512.83
5 Years Annualised13.4911.2813.36
10 Years Annualised14.3013.3414.21

Morningstar SRRI

Lower Risk
Higher Risk
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
Potentially Lower ReturnsPotentially Higher Returns
Source: Morningstar

Investment Objective

The objective of the Fund is to secure capital growth from a portfolio of securities representing companies engaged in Health, Pharmaceuticals and Biotechnology. Securities representing all such companies in the FTSE World Index will be held with weightings generally proportionate to their market capitalisation.

Portfolio Profile30/04/2018

Morningstar Style Box®

Equity Style

Large, Mid, SmallSize
Value, Blend, Growth
Style
Top Holdings
NameSector%
IncreaseDecreaseNew since last portfolio
DecreaseJohnson & Johnson Healthcare7.41
IncreaseUnitedHealth Group Inc Healthcare4.94
DecreasePfizer Inc Healthcare4.69
DecreaseNovartis AG Healthcare3.62
IncreaseMerck & Co Inc Healthcare3.52
Asset Allocation %
LongShortNet
Stocks99.270.0099.27
Bonds0.000.000.00
Cash0.730.000.73
Other0.000.000.00
Top Stock Regions
Region%
United States66.14
Europe - ex Euro10.89
Eurozone8.21
Japan5.94
United Kingdom4.59
Top Stock Sectors
Stock Sector%
Healthcare99.69
Basic Materials0.17
Consumer Defensive0.11
Consumer Cyclical0.03
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2019 Morningstar. All rights reserved.